Wednesday, December 1 | 11 a.m. CST

About

How’s enrollment going in the study (started in October 2020) and what’s the evidence behind this intervention?

 

Learning objective(s):

  • Understand why nutrition research needs pilot/feasibility studies before larger clinical trials.
  • Learn what do we know about the KETO diet as an intervention in animal PKD vs. human PKD.
  • Increase knowledge of PKDF’s funded research programs and projects.

Speaker

Roman-Ulrich Müller

Roman-Ulrich Müller

University Hospital Cologne

Dr. Müller is Vice Director of the Department 2 for Internal Medicine (Renal Unit) at the University Hospital Cologne. He began his medical career at the universities of Freiburg and Heidelberg in Germany. After finishing medical school, Dr. Müller completed his scientific training at Rockefeller University (New York, USA) and Yale University (New Haven, USA). He then returned to Germany to obtain his board certification in Nephrology in the Department of Prof. Benzing at University Hospital Cologne where he now works.

Here, Dr. Müller is head of the ADPKD unit (website) and has established the „AD(H)PKD Registry“, which strives to collect information on the management of ADPKD and has become one of the largest cohorts worldwide. Furthermore, he leads a basic research group that tackles the molecular mechanisms underlying kidney disease, employing modern techniques in molecular biology and biochemistry (website). His special interest is dedicated to renal RNA biology — e.g. RNA-binding proteins and non-coding RNAs — including the discovery of small non-coding RNAs in polycystic disease. Research in Dr. Müller’s laboratory has been funded by grants from federal agencies, including the German Research Foundation and the Ministry of Science North-Rhine Westphalia, by private foundations, including the Marga and Walter Boll Foundation and the German Kidney Foundation, as well as several companies involved in biotechnology and medicine. Based on this work, Dr. Müller is the author of numerous publications on clinical and molecular nephrology in renowned journals.

Whenever this leaves time for other activities, Roman loves to discover the world, no matter whether by campervan, bicycle or — as required by the current pandemic — online.

Related Resources

Manual para pacientes con ERPAD: Entender y vivir con la enfermedad renal poliquística autosómica dominante

Manual para pacientes con ERPAD: Entender y vivir con la enfermedad renal poliquística autosómica dominante

El propósito de este manual es proporcionar información sobre la enfermedad renal poliquística autosómica dominante (ERPAD). Será un documento útil para aquellas personas que tienen la enfermedad, para las que tienen riesgo de tenerla debido a un progenitor afectado, así como para los familiares y amigos involucrados. No está dirigido a los pacientes con enfermedad renal poliquística autosómica recesiva (ERPAR). Para los pacientes con esta enfermedad, hay un manual disponible en pkdcure.org. En lo sucesivo, nos referiremos a la ERPAD simplemente como ERP.

Understanding Lab Results

Understanding Lab Results

Tuesday, November 16, 2021 | 7 p.m. CDT

Labs provide you and your doctor with valuable information about your overall health and your kidney function. It is important to understand the labs that your doctor requests, track your results, and know when specific labs are or are not within the normal range.